483 related articles for article (PubMed ID: 19121414)
1. Strain-specific immunity may drive adaptive polymorphism in the merozoite surface protein 1 of the rodent malaria parasite Plasmodium chabaudi.
Cheesman S; Tanabe K; Sawai H; O'Mahony E; Carter R
Infect Genet Evol; 2009 Mar; 9(2):248-55. PubMed ID: 19121414
[TBL] [Abstract][Full Text] [Related]
2. A single parasite gene determines strain-specific protective immunity against malaria: the role of the merozoite surface protein I.
Cheesman S; O'Mahony E; Pattaradilokrat S; Degnan K; Knott S; Carter R
Int J Parasitol; 2010 Jul; 40(8):951-61. PubMed ID: 20153748
[TBL] [Abstract][Full Text] [Related]
3. Linkage group selection: towards identifying genes controlling strain specific protective immunity in malaria.
Pattaradilokrat S; Cheesman SJ; Carter R
PLoS One; 2007 Sep; 2(9):e857. PubMed ID: 17848988
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
5. Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species.
O'Donnell RA; Saul A; Cowman AF; Crabb BS
Nat Med; 2000 Jan; 6(1):91-5. PubMed ID: 10613831
[TBL] [Abstract][Full Text] [Related]
6. Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope of Plasmodium falciparum merozoite surface protein 1 displaying dimorphic amino acid polymorphism are highly constrained.
Daubenberger CA; Nickel B; Ciatto C; Grütter MG; Pöltl-Frank F; Rossi L; Siegler U; Robinson J; Kashala O; Patarroyo ME; Pluschke G
Eur J Immunol; 2002 Dec; 32(12):3667-77. PubMed ID: 12516559
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross-protects A/J mice against challenge with P. c. adami DK and virulent Plasmodium chabaudi chabaudi AS parasites.
Scorza T; Grubb K; Cambos M; Santamaria C; Tshikudi Malu D; Spithill TW
Int J Parasitol; 2008 Jun; 38(7):819-27. PubMed ID: 18062974
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.
Kaushal DC; Kaushal NA; Narula A; Kumar N; Puri SK; Dutta S; Lanar DE
Indian J Biochem Biophys; 2007 Dec; 44(6):429-36. PubMed ID: 18320841
[TBL] [Abstract][Full Text] [Related]
9. Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite.
Kang Y; Calvo PA; Daly TM; Long CA
J Immunol; 1998 Oct; 161(8):4211-9. PubMed ID: 9780195
[TBL] [Abstract][Full Text] [Related]
10. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
Burns JM; Flaherty PR; Nanavati P; Weidanz WP
Infect Immun; 2004 Oct; 72(10):5605-12. PubMed ID: 15385457
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism in Plasmodium falciparum vaccine candidate antigens.
Mahajan RC; Farooq U; Dubey ML; Malla N
Indian J Pathol Microbiol; 2005 Oct; 48(4):429-38. PubMed ID: 16366089
[TBL] [Abstract][Full Text] [Related]
12. Recent independent evolution of msp1 polymorphism in Plasmodium vivax and related simian malaria parasites.
Tanabe K; Escalante A; Sakihama N; Honda M; Arisue N; Horii T; Culleton R; Hayakawa T; Hashimoto T; Longacre S; Pathirana S; Handunnetti S; Kishino H
Mol Biochem Parasitol; 2007 Nov; 156(1):74-9. PubMed ID: 17706800
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium chabaudi: immunogenicity of a highly antigenic glutamate-rich protein.
Wiser MF; Giraldo LE; Schmitt-Wrede HP; Wunderlich F
Exp Parasitol; 1997 Jan; 85(1):43-54. PubMed ID: 9024201
[TBL] [Abstract][Full Text] [Related]
14. Genetic diversity in the C-terminal 42 kDa region of merozoite surface protein-1 of Plasmodium vivax (PvMSP-1(42)) among Indian isolates.
Thakur A; Alam MT; Sharma YD
Acta Trop; 2008 Oct; 108(1):58-63. PubMed ID: 18823930
[TBL] [Abstract][Full Text] [Related]
15. Different regions of the malaria merozoite surface protein 1 of Plasmodium chabaudi elicit distinct T-cell and antibody isotype responses.
Quin SJ; Langhorne J
Infect Immun; 2001 Apr; 69(4):2245-51. PubMed ID: 11254580
[TBL] [Abstract][Full Text] [Related]
16. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
17. Orthologous gene sequences of merozoite surface protein 1 (MSP1) from Plasmodium reichenowi and P. gallinaceum confirm an ancient divergence of P. falciparum alleles.
Polley SD; Weedall GD; Thomas AW; Golightly LM; Conway DJ
Mol Biochem Parasitol; 2005 Jul; 142(1):25-31. PubMed ID: 15907558
[TBL] [Abstract][Full Text] [Related]
18. Quantifying variation in the potential for antibody-mediated apparent competition among nine genotypes of the rodent malaria parasite Plasmodium chabaudi.
Fairlie-Clarke KJ; Allen JE; Read AF; Graham AL
Infect Genet Evol; 2013 Dec; 20():270-5. PubMed ID: 24056014
[TBL] [Abstract][Full Text] [Related]
19. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses.
Conway DJ; Cavanagh DR; Tanabe K; Roper C; Mikes ZS; Sakihama N; Bojang KA; Oduola AM; Kremsner PG; Arnot DE; Greenwood BM; McBride JS
Nat Med; 2000 Jun; 6(6):689-92. PubMed ID: 10835687
[TBL] [Abstract][Full Text] [Related]
20. Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1.
Burns JM; Flaherty PR; Romero MM; Weidanz WP
Vaccine; 2003 May; 21(17-18):1843-52. PubMed ID: 12706668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
